Latest Breaking News On - Non clear cell renal carcinoma - Page 1 : comparemela.com

Nivolumab Plus Cabozantinib in Non–Clear Cell RCC

David A. Braun, MD, PhD, highlights recent data focused on nivolumab plus cabozantinib in patients with non–clear cell renal cell carcinoma.

KEYNOTE-B61: Lenvatinib Plus Pembrolizumab in Non–Clear Cell RCC

Focusing on the KEYNOTE-B61 trial evaluating lenvatinib plus pembrolizumab in the first line, a panel of medical oncologists react to clinical trial data on combination regimens in non–clear cell renal cell carcinoma.

Overview of Non–Clear Cell RCC

The expert panel gives an overview of non–clear cell renal cell carcinoma, highlighting disease subtypes and treatment approaches.

First-Line Treatments for Advanced Clear Cell RCC

A panel of medical oncologists who specialize in renal cell carcinoma (RCC) introduce themselves and discuss the first-line treatment landscape and risk stratification of clear cell RCC.

Eisai Aims to Advance Genitourinary Cancer Treatment with New Research at ASCO GU 2024